Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.

MLA

Nakamura, Kenta, et al. “Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.” Circulation. Cardiovascular Interventions, vol. 17, no. 5, May 2024, p. e014054. EBSCOhost, https://doi.org/10.1161/CIRCINTERVENTIONS.124.014054.

APA

Nakamura, K., Henry, T. D., Traverse, J. H., Latter, D. A., Mokadam, N. A., Answini, G. A., Williams, A. R., Sun, B. C., Burke, C. R., Bakaeen, F. G., DiCarli, M. F., Chaitman, B. R., Peterson, M. W., Byrnes, D. G., Ohman, E. M., Pepine, C. J., Crystal, R. G., Rosengart, T. K., Kowalewski, E., … Povsic, T. J. (2024). Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial. Circulation. Cardiovascular Interventions, 17(5), e014054. https://doi.org/10.1161/CIRCINTERVENTIONS.124.014054

Chicago

Nakamura, Kenta, Timothy D Henry, Jay H Traverse, David A Latter, Nahush A Mokadam, Geoffrey A Answini, Adam R Williams, et al. 2024. “Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial.” Circulation. Cardiovascular Interventions 17 (5): e014054. doi:10.1161/CIRCINTERVENTIONS.124.014054.